Cullen/Frost Bankers, Inc. Takeda Pharmaceutical CO LTD Transaction History

Cullen/Frost Bankers, Inc.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 07, 2022	BUY	$12.8 - $28.65 $11,558 - $25,870	903 New	903 $12,000
Q1 2022 May 09, 2022	SELL	$13.54 - $15.35 $1,692 - $1,918	-125 Closed	0 $0
Q4 2020 Feb 08, 2021	SELL	$15.39 - $18.97 $3,401 - $4,192	-221 Reduced 63.87%	125 $2,000
Q3 2020 Nov 05, 2020	SELL	$17.1 - $19.19 $31,925 - $35,827	-1,867 Reduced 84.37%	346 $6,000
Q2 2020 Aug 05, 2020	BUY	$14.59 - $19.5 $27,969 - $37,381	1,917 Added 647.64%	2,213 $40,000

Q1 2020 May 01, 2020	SELL	$13.02 - $20.31 $2,356 - $3,676	-181 Reduced 37.95%	296 $4,000
Q4 2019 Feb 06, 2020	SELL	$16.88 - $20.83 $31,886 - $39,347	-1,889 Reduced 79.84%	477 $9,000
Q3 2019 Nov 01, 2019	BUY	$16.15 - $17.99 $2,357 - $2,626	146 Added 6.58%	2,366 $41,000
Q2 2019 Aug 01, 2019	SELL	$16.58 - $20.49 $67,347 - $83,230	-4,062 Reduced 64.66%	2,220 $39,000
Q1 2019 Apr 30, 2019	BUY	$16.7 - $21.52 $104,909 - $135,188	6,282 New	6,282 $128,000

340

76M

1.85M

121K

Ticker TAK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 3,109,050,112
Market Cap $41B
Description
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...

Get notified when there are updates to the investment portfolio of Cullen/Frost Bankers, Inc., based on Form 13F filings with the SEC.

Stay updated on Cullen/Frost Bankers, Inc. with notifications on news.